Leadership & Pay · · GlobeNewswire
Annovis Bio Promotes Cheng Fang to Chief Scientific Officer
ANVSAnnovis Bio, Inc.
Annovis Bio Inc. announced the promotion of Cheng Fang, Ph.D., from Senior Vice President of Research and Development to Chief Scientific Officer on July 1, 2026. Dr. Fang will lead scientific strategy and research operations for Alzheimer’s disease and Parkinson’s disease programs as the company advances its lead candidate buntanetap toward Phase 3 data readout. Annovis Bio is a clinical-stage biotechnology company developing treatments for neurodegenerative diseases.